Fig. 8From: Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugateThe antitumor activity of PTK7-GEMs in a model of in-situ bladder cancer model. AÂ Photographs of H&E-stained tissue sections (muscle invasive bladder cancer at stage pT2 or higher and excised bladders after treatment with PBS. BÂ Photographs of H&E-stained tissue sections (muscle invasive bladder cancer at stage pT2 or higher and excised bladders after treatment with PTK7. (C) Photographs of H&E-stained tissue sections (muscle invasive bladder cancer at stage pT2 or higher and excised bladders after treatment with LIB. DÂ Photographs of H&E-stained tissue sections (noninvasive papillary carcinoma: stage pT1) and excised bladders after treatment with GEM. EÂ Photographs of H&E-stained tissue sections (noninvasive papillary carcinoma: stage pT1) and excised bladders after treatment with LIB-GEMs. FÂ Photographs of H&E-stained tissue sections (noninvasive papillary carcinoma: at stage pTa or lower) and excided bladders after treatment with PTK7-GEMs.Back to article page